Literature DB >> 31890692

Inflammation related miRNAs as an important player between obesity and cancers.

Morteza Gholami1,2, Bagher Larijani2, Zhila Zahedi2, Fatemeh Mahmoudian3, Samira Bahrami4, Sima Parvizi Omran5, Zahra Saadatian6, Shirin Hasani-Ranjbar1, Reza Taslimi7, Milad Bastami8, Mahsa M Amoli5.   

Abstract

The growing trend in addition to their burden, prevalence, and death has made obesity and cancer two of the most concerning diseases worldwide. Obesity is an important risk factor for common types of cancers where the risk of some cancers is directly related to the obesity. Various inflammatory mechanisms and increased level of pro-inflammatory cytokines have been investigated in many previous studies, which play key roles in the pathophysiology and development of both of these conditions. On the other hand, in the recent years, many studies have individually focused on the biomarker's role and therapeutic targeting of microRNAs (miRNAs) in different types of cancers and obesity including newly discovered small noncoding RNAs (sncRNAs) which regulate gene expression and RNA silencing. This study is a comprehensive review of the main inflammation related miRNAs in obesity/obesity related traits. For the first time, the main roles of miRNAs in obesity related cancers have been discussed in response to the question raised in the following hypothesis; do the main inflammatory miRNAs link obesity with obesity-related cancers regarding their role as biomarkers? Graphical abstractConceptual design of inflammatory miRNAs which provide link between obesity and cancers. © Springer Nature Switzerland AG 2019.

Entities:  

Keywords:  Cancer; Inflammation; MicroRNAs; Obesity

Year:  2019        PMID: 31890692      PMCID: PMC6915181          DOI: 10.1007/s40200-019-00459-2

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  223 in total

Review 1.  Endocrinology of adipose tissue - an update.

Authors:  P Fischer-Posovszky; M Wabitsch; Z Hochberg
Journal:  Horm Metab Res       Date:  2007-05       Impact factor: 2.936

2.  MicroRNA-125b mimic inhibits ischemia reperfusion-induced neuroinflammation and aberrant p53 apoptotic signalling activation through targeting TP53INP1.

Authors:  Xiao-Qian Li; Qian Yu; Wen-Fei Tan; Zai-Li Zhang; Hong Ma
Journal:  Brain Behav Immun       Date:  2018-09-05       Impact factor: 7.217

3.  MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation.

Authors:  Francisco J Ortega; José M Moreno-Navarrete; Gerard Pardo; Monica Sabater; Manuela Hummel; Anna Ferrer; Jose I Rodriguez-Hermosa; Bartomeu Ruiz; Wifredo Ricart; Belen Peral; José M Fernández-Real
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

4.  Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation.

Authors:  Naomi Hosogai; Atsunori Fukuhara; Kazuya Oshima; Yugo Miyata; Sachiyo Tanaka; Katsumori Segawa; Shigetada Furukawa; Yoshihiro Tochino; Ryutaro Komuro; Morihiro Matsuda; Iichiro Shimomura
Journal:  Diabetes       Date:  2007-04       Impact factor: 9.461

5.  miR-132 inhibits lipopolysaccharide-induced inflammation in alveolar macrophages by the cholinergic anti-inflammatory pathway.

Authors:  Fen Liu; Yong Li; Rong Jiang; Cheng Nie; Zhenguo Zeng; Ning Zhao; Caixue Huang; Qiang Shao; Chengzhi Ding; Cheng Qing; Liang Xia; Erming Zeng; Kejian Qian
Journal:  Exp Lung Res       Date:  2015-06       Impact factor: 2.459

6.  A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation.

Authors:  Guoqing Zhuang; Cong Meng; Xin Guo; Patali S Cheruku; Lei Shi; Hang Xu; Honggui Li; Gang Wang; Ashley R Evans; Stephen Safe; Chaodong Wu; Beiyan Zhou
Journal:  Circulation       Date:  2012-05-11       Impact factor: 29.690

Review 7.  Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.

Authors:  Guofeng Cheng
Journal:  Adv Drug Deliv Rev       Date:  2014-09-16       Impact factor: 15.470

8.  Identification of hsa-miR-335 as a prognostic signature in gastric cancer.

Authors:  Zhi Yan; Yimin Xiong; Weitian Xu; Juan Gao; Yi Cheng; Zhigang Wang; Fang Chen; Guorong Zheng
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

9.  MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism.

Authors:  Masayoshi Ishida; Michio Shimabukuro; Shusuke Yagi; Sachiko Nishimoto; Chisayo Kozuka; Daiju Fukuda; Takeshi Soeki; Hiroaki Masuzaki; Masato Tsutsui; Masataka Sata
Journal:  PLoS One       Date:  2014-11-07       Impact factor: 3.240

10.  Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020.

Authors:  Hannah K Weir; Robert N Anderson; Sallyann M Coleman King; Ashwini Soman; Trevor D Thompson; Yuling Hong; Bjorn Moller; Steven Leadbetter
Journal:  Prev Chronic Dis       Date:  2016-11-17       Impact factor: 2.830

View more
  4 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  An in silico approach to identify and prioritize miRNAs target sites polymorphisms in colorectal cancer and obesity.

Authors:  Morteza Gholami; Marzieh Zoughi; Bagher Larijani; Mahsa M Amoli; Milad Bastami
Journal:  Cancer Med       Date:  2020-10-18       Impact factor: 4.452

Review 3.  Cellular and Molecular Players in the Interplay between Adipose Tissue and Breast Cancer.

Authors:  Francesca Reggiani; Paolo Falvo; Francesco Bertolini
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

4.  Overexpression of miR-651-5p inhibits ultraviolet radiation-induced malignant biological behaviors of sebaceous gland carcinoma cells by targeting ZEB2.

Authors:  Haiyan Zhao; Xiaochun Yang; Juan Liu; Fang Han; Zhengrong Yang; Zhongyin Hu; Mingzhi Liu; Yan Mei
Journal:  Ann Transl Med       Date:  2022-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.